Tumor necrosis factor (TNF)-α is a pro-inflammatory cytokine associated with psoriasis pathogenesis. Anti-TNF-α therapies are effective in psoriasis. A significant weight gain has been reported in patients treated with anti-TNF-α agents. The aim of the present study was to evaluate the body composition changes in psoriatic patients receiving anti-TNF-α therapies according with disease phenotype. Forty patients affected with psoriasis were followed up for 24 weeks and divided into two groups: psoriasis vulgaris (PsO) and psoriatic arthritis (PsA). Anthropometric, blood biochemical, body composition parameters, resting metabolic rate, and disease activity indexes ...
Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment is a post from: Skincare
Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment via BuzzBlazer.com
No comments:
Post a Comment